Literature DB >> 25987307

Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.

Frederico O Gleber-Netto1, Boudewijn J M Braakhuis2, Asterios Triantafyllou3, Robert P Takes4, Natalie Kelner5, Juan P Rodrigo6, Primož Strojan7, Vincent Vander Poorten8, Alexander D Rapidis9, Alessandra Rinaldo10, Ruud H Brakenhoff2, Alfio Ferlito11, Luiz P Kowalski12.   

Abstract

Relapses have a great impact on both the morbidity and mortality rates of oral squamous cell carcinoma (OSCC) patients. Current classification criteria are imprecise and need improvements. Recent advances in understanding of OSCC relapses on a molecular level provide new possibilities to better classify true recurrences and second primary tumors. This review discusses the limitations of the current OSCC relapse classification method and presents possible alternatives to improve this classification based on molecular techniques. Moreover, these molecular techniques add to the further understanding of these lesions and may provide tools for clinical management.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Molecular diagnosis; Oral cancer; Recurrence; Relapse; Second primary neoplasm; Squamous cell carcinoma

Mesh:

Year:  2015        PMID: 25987307     DOI: 10.1016/j.oraloncology.2015.04.016

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.

Authors:  Susan R Mallery; Daren Wang; Brian Santiago; Ping Pei; Caroline Bissonnette; Jayanetti Asiri Jayawardena; Steven P Schwendeman; Richard Spinney; James Lang
Journal:  Mol Cancer Ther       Date:  2019-09-12       Impact factor: 6.261

2.  Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.

Authors:  Susan R Mallery; Daren Wang; Brian Santiago; Ping Pei; Steven P Schwendeman; Kari Nieto; Richard Spinney; Meng Tong; George Koutras; Brian Han; Andrew Holpuch; James Lang
Journal:  Cancer Prev Res (Phila)       Date:  2016-10-18

3.  Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.

Authors:  Joost H van Ginkel; Manon M H Huibers; Robert J J van Es; Remco de Bree; Stefan M Willems
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

4.  Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.

Authors:  Linda Boldrup; Xiaolian Gu; Philip J Coates; Lena Norberg-Spaak; Robin Fahraeus; Göran Laurell; Torben Wilms; Karin Nylander
Journal:  Oncotarget       Date:  2017-03-21

5.  DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.

Authors:  Elena Padin-Iruegas; Cintia M Chamorro-Petronacci; Iria Sines-Cajade; Alejandro I Lorenzo-Pouso; Andrés Blanco-Carrión; Alba Pérez-Jardón; Pilar Gándara-Vila; Mario Pérez-Sayans
Journal:  Medicina (Kaunas)       Date:  2022-06-30       Impact factor: 2.948

6.  Microsatellite alteration in head and neck squamous cell carcinoma patients from a betel quid-prevalent region.

Authors:  Jin-Ching Lin; Chen-Chi Wang; Rong-San Jiang; Wen-Yi Wang; Shih-An Liu
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

7.  Inhibition of αvβ3 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC).

Authors:  Cyntia F Montenegro; Bruna C Casali; Rafael L B Lino; Bianca C Pachane; Patty K Santos; Alan R Horwitz; Heloisa S Selistre-de-Araujo; Marcelo L Lamers
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

8.  Expression of Ki-67, Cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC).

Authors:  Padmanabha Kumar Govindaraj; Thomas George Kallarakkal; Rosnah Mohd Zain; Wanninayake Mudiyanselage Tilakaratne; Huai Lin Lew
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

9.  Characterization of genomic clones by targeted deep sequencing of ctDNA to monitor liver cancer.

Authors:  Yan Sun; Xiaoyu Kong; Jing Yu; Xiaolin Zheng; Mufei Lin; Zhengyu Cheng; Hui Wang; Na An; Ying Xie; Shuang Zeng; Siming Xue; Min Xia; Xia Wei; Lijie Song; Fengxia Liu; Chunna Fan; Zhonghai Fang; Liangjun Gao; Yun Yang; Shida Zhu; Taiping Shi
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

Review 10.  Contribution of Genomics to the Surgical Management and Study of Oral Cancer.

Authors:  Zuzana Saidak; Claire Lailler; Sylvie Testelin; Bruno Chauffert; Florian Clatot; Antoine Galmiche
Journal:  Ann Surg Oncol       Date:  2021-04-12       Impact factor: 5.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.